×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Valneva Announces Sale of Priority Review Voucher for $103 Million
Valneva
Valneva sold the Priority Review Voucher it received from the U.S. Food and Drug Administration for $103 million (€95 million).
2 months ago
Valneva rallies behind launch of its new chikungunya vaccine
Fierce Pharma
After coming up short in its attempt to find a niche for its COVID vaccine, Valneva is focused on launching its new chikungunya virus...
6 days ago
Valneva guides for nearly double product sales by 2026
Reuters
France's Valneva on Wednesday said it expects to nearly double its annual product sales by 2026 and edged up its 2024 product sales guidance...
1 month ago
Valneva shares slump after COVID vaccine deal with EU falls apart
Yahoo Movies UK
(Reuters) -Valneva lost nearly a fifth of its value on Monday after the French drugmaker said its COVID-19 vaccine agreement with the...
3 days ago
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
Valneva
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook · Total revenues of €153.7 million, including product sales of...
1 month ago
Valneva commences trial of second-generation Zika vaccine
Clinical Trials Arena
Valneva has commenced the Phase I trial of its second-generation inactivated vaccine candidate, VLA1601, against the Zika virus (ZIKV).
1 month ago
Valneva adjusts 2023 financial guidance after priority voucher sale delay
Pharmaceutical Technology
Valneva adjusts 2023 financial guidance after priority voucher sale delay. Valneva's CFO said the company is waiting to sell the voucher, which...
3 months ago
Valneva sells chikungunya vaccine priority review voucher for $103 mln
Reuters
French vaccine maker Valneva said on Monday it had sold the priority review voucher (PRV) it received from the U.S. Food and Drug...
2 months ago
Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript
Yahoo Finance
Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript March 20, 2024 Valneva SE misses on earnings expectations.
1 month ago
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine
Valneva
There is currently no approved chikungunya vaccine for children and Valneva's vaccine IXCHIQ® is currently the only licensed chikungunya vaccine...
3 months ago